Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394706 · ClinicalTrials.gov registry record · Phase 3
Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve
A Phase 3 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 3
- Development phase
- 11,738
- Enrollment target
NCT00394706 is a Phase 3 study that was terminated before completion, run by University of Washington. The registered enrollment target is 11,738 participants.
The verdict
NCT00394706, a Phase 3 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 11,738 participants
- Enrollment target
Study Summary
The purpose of this study is to look at two different treatments during a cardiac arrest that occurs outside of the hospital and whether either or both treatments will increase the number of people who live to hospital discharge. A cardiac arrest is when the heart stops pumping blood to the body.
Interventions
- DEVICE Impedance Threshold Device (ITD)
- DEVICE Sham ITD
- OTHER Analyze early
- OTHER Analyze later
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,738 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00394706
The ClinicalTrials.gov registry entry for NCT00394706 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 11,738 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Impedance Threshold Device (ITD) is the first listed.
NCT00394706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00394706 about?
NCT00394706 is a clinical study titled "Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve". The purpose of this study is to look at two different treatments during a cardiac arrest that occurs outside of the hospital and whether either or both treatments will increase the number of people who live to hospital discharge. A cardiac arrest is when the heart stops pumping blood to the body.
What is the current status of trial NCT00394706?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 11,738 participants. The study started on 2007-06. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00394706?
The interventions under investigation include: Impedance Threshold Device (ITD) (DEVICE), Sham ITD (DEVICE), Analyze early (OTHER), Analyze later (OTHER).
Who is sponsoring clinical trial NCT00394706?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.